Evidence map›Paper›PMID 39599662›Full record

ArticleNutrients2024

Protective Effects of Isostrictiniin Against High-Fat, High-Sugar Diet-Induced Steatosis in MASLD Mice via Regulation of the AMPK/SREBP-1c/ACC Pathway.

Qi Yan, Chenyang Li, Jinfeng Li, Yuhan Yao, Jun Zhao

Abstract read
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Polyphenol-RichNutrients · 2026
    Article
  2. Total Flavonoids ofNutrients · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. A Novel Sesquiterpene fromMolecules (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qi YanSchool of Pharmacy, Xinjiang Medical University, Urumqi 830011, China.ORCID 0009-0005-1956-904X
Chenyang LiXinjiang Key Laboratory for Uighur Medicine, Institute of Materia Medica of Xinjiang, Urumqi 830004, China.ORCID 0000-0001-9984-0541
Jinfeng LiSchool of Life Science and Technology, Xinjiang University, Urumqi 830046, China.
Yuhan YaoXinjiang Key Laboratory for Uighur Medicine, Institute of Materia Medica of Xinjiang, Urumqi 830004, China.
Jun ZhaoSchool of Pharmacy, Xinjiang Medical University, Urumqi 830011, China.ORCID 0000-0001-9890-4582

Funding

Major Science and Technology Projects in Xinjiang Uygur Autonomous Region in China 2022A03018-1
6 · The paper itself

Abstract

objectivesIsostrictiniin (ITN), a natural polyphenol extracted from

methodsKunming mice were randomly divided into normal control and HFSD groups. After being fed for 4 weeks, the HFSD group was randomly divided into model, atorvastatin calcium (ATC; 10 mg/kg), and ITN (25, 50, and 100 mg/kg) groups. After continued feeding for 4 weeks, the biochemical indexes in the mice were determined.

resultsCompared with the model group, the liver index; FBG; HOMA-IR; serum AST, ALT, TG, TC, and LDL-C; and liver MDA, IL-6, TNF-α, and IL-1β levels in the ITN (25, 50, and 100 mg/kg) and ATC (10 mg/kg) groups were significantly decreased (

conclusionsITN can significantly improve MASLD mice, and its mechanism may be related to the regulation of the AMPK/SREBP-1c/ACC pathway.

Indexed as

Acetyl-CoA CarboxylaseAMP-Activated Protein KinasesDiet, High-FatLiverSterol Regulatory Element Binding Protein 1AnimalsAnimals, Outbred StrainsDietary SugarsDisease Models, AnimalFatty LiverMaleMiceNon-alcoholic Fatty Liver DiseaseSignal TransductionAcetyl-CoA CarboxylaseAMP-Activated Protein KinasesDietary SugarsSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1AMPK/SREBP-1c/ACC pathwayhigh-fat–high-sugar dietsisostrictiniinMSALD

Identifiers

PMID39599662
PMCPMC11597722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.